Search Results - "Pearce, Rachel M"

Impact of positron emission tomography - computed tomography status on progression-free survival for relapsed follicular lymphoma patients undergoing autologous stem cell transplantation by Eyre, Toby A, Barrington, Sally F, Okosun, Jessica, Abamba, Clementina, Pearce, Rachel M, Lee, Julia, Carpenter, Ben, Crawley, Charles R, Bloor, Adrian J C, Gilleece, Maria, Nicholson, Emma, Shah, Nimish, Orchard, Kim, Malladi, Ram, Townsend, William M

“…The optimum management approach for patients with relapsed or refractory follicular lymphoma remains uncertain. Autologous stem cell transplantation (autoSCT)…”
Get full text

Favorable outcomes with alemtuzumab-conditioned unrelated donor stem cell transplantation in adults with high-risk Philadelphia chromosome-negative acute lymphoblastic leukemia in first complete remission by Patel, Bella, Kirkland, Keiren E, Szydlo, Richard, Pearce, Rachel M, Clark, Richard E, Craddock, Charles, Liakopoulou, Effie, Fielding, Adele K, Mackinnon, Stephen, Olavarria, Eduardo, Potter, Mike N, Russell, Nigel H, Shaw, Bronwen E, Cook, Gordon, Goldstone, Anthony H, Marks, David I

“…1 Department of Haematology, Royal Free and University College London Medical School, London 2 BSBMT Data Registry, Guy’s Hospital, London 3 Department of…”
Get full text

Electrocardiographic QT Interval Prolongation and Risk of Primary Cardiac Arrest in Diabetic Patients by Whitsel, Eric A, Boyko, Edward J, Rautaharju, Pentti M, Raghunathan, Trivellore E, Lin, Danyu, Pearce, Rachel M, Weinmann, Sheila A, Siscovick, David S

“…Whitsel et al conduct a case-control study of primary cardiac arrest (PCA) in a large prepaid health plan, Group Health Cooperative of Puget Sound. They…”
Get full text

Presence of donor-encoded centromeric KIR B content increases the risk of infectious mortality in recipients of myeloablative, T-cell deplete, HLA-matched HCT to treat AML by Bultitude, Will P., Schellekens, Jennifer, Szydlo, Richard M., Anthias, Chloe, Cooley, Sarah A., Miller, Jeffrey S., Weisdorf, Daniel J., Shaw, Bronwen E., Roberts, Chrissy h., Garcia-Sepulveda, Christian A., Lee, Julia, Pearce, Rachel M., Wilson, Marie C., Potter, Michael N., Byrne, Jenny L., Russell, Nigel H., MacKinnon, Stephen, Bloor, Adrian J., Patel, Amit, McQuaker, I. Grant, Malladi, Ram, Tholouli, Eleni, Orchard, Kim, Potter, Victoria T., Madrigal, J. Alejandro, Mayor, Neema P., Marsh, Steven G. E.

“…The reported influence of donor Killer-cell Immunoglobulin-like Receptor (KIR) genes on the outcomes of haematopoietic cell transplantation (HCT) are…”
Get full text

Haematopoietic stem cell transplantation (HSCT) in severe autoimmune diseases: analysis of UK outcomes from the British Society of Blood and Marrow Transplantation (BSBMT) data registry 1997-2009 by Snowden, John A., Pearce, Rachel M., Lee, Julia, Kirkland, Keiren, Gilleece, Maria, Veys, Paul, Clark, Richard E., Kazmi, Majid, Abinun, Mario, Jackson, Graham H., Mackinnon, Stephen, Russell, Nigel H., Cook, Gordon

“…Summary The British Society of Blood and Marrow Transplantation Data Registry was used to analyse outcomes of haematopoietic stem cell transplantation (HSCT)…”
Get full text

Incidence of Out-of-Hospital cardiac arrest by Rea, Thomas D, Pearce, Rachel M, Raghunathan, Trivellore E, Lemaitre, Rozenn N, Sotoodehnia, Nona, Jouven, Xavier, Siscovick, David S

“…Estimates of the incidence of out-of-hospital primary cardiac arrest (CA) have typically relied solely upon emergency medical service or death certificate…”
Get full text

Cell membrane trans-fatty acids and the risk of primary cardiac arrest by LEMAITRE, Rozenn N, KING, Irena B, RAGHUNATHAN, Trivellore E, PEARCE, Rachel M, WEINMANN, Sheila, KNOPP, Robert H, COPASS, Michael K, COBB, Leonard A, SISCOVICK, David S

“…The relation of trans-fatty acid intake to life-threatening arrhythmias and primary cardiac arrest is unknown. We investigated the association of trans-fatty…”
Get full text

Unrelated donor peripheral blood stem cell transplants incorporating pre‐transplant in‐vivo Alemtuzumab are not associated with any increased risk of significant acute or chronic graft‐versus‐host disease by Shaw, Bronwen E., Apperley, Jane F., Russell, Nigel H., Craddock, Charles, Liakopoulou, Effie, Potter, Michael N., Wynn, Robert, Gibson, Brenda, Pearce, Rachel M., Kirkland, Keiren, Lee, Julia, Madrigal, J. Alejandro, Cook, Gordon, Byrne, Jennifer L.

“…Summary There is little information published comparing peripheral blood stem cells (PBSC) with bone marrow (BM) as the stem cell source in the long‐term…”
Get full text

Genetic variants of platelet glycoprotein receptors and risk of stroke in young women by REINER, A. P, KUMAR, P. N, SCHWARTZ, S. M, LONGSTRETH, W. T, PEARCE, R. M, ROSENDAAL, F. R, PSATY, B. M, SISCOVICK, D. S

“…A number of studies have examined the relationship between genetic platelet glycoprotein variants and early-onset atherothrombotic disease, particularly acute…”
Get full text

Outcome of Donor Lymphocyte Infusion after T Cell–depleted Allogeneic Hematopoietic Stem Cell Transplantation for Acute Myelogenous Leukemia and Myelodysplastic Syndromes by Krishnamurthy, Pramila, Potter, Victoria T, Barber, Linda D, Kulasekararaj, Austin G, Lim, Zi Yi, Pearce, Rachel M, de Lavallade, Hugues, Kenyon, Michelle, Ireland, Robin M, Marsh, Judith C.W, Devereux, Stephen, Pagliuca, Antonio, Mufti, Ghulam J

“…Abstract Relapse occurs in 30%-50% of recipients of T cell–depleted (TCD) reduced-intensity conditioned (RIC) hematopoietic stem cell transplantation (HSCT)…”
Get full text

Autologous Stem Cell Transplantation Is an Effective Salvage Therapy for Primary Refractory Multiple Myeloma by Parrish, Christopher, Rahemtulla, Amin, Cavet, Jim, Pearce, Rachel M, Kirkland, Keiren, Lee, Julia, Cook, Mark, Wilson, Keith, Cook, Gordon

“…Abstract High-dose therapy and autologous stem cell transplantation (ASCT) have proven efficacy in patients with multiple myeloma responding well to induction…”
Get full text

Inhaled beta-2 adrenergic receptor agonists and primary cardiac arrest by Lemaitre, Rozenn N, Siscovick, David S, Psaty, Bruce M, Pearce, Rachel M, Raghunathan, Trivellore E, Whitsel, Eric A, Weinmann, Sheila A, Anderson, Gail D, Lin, Danyu

“…We sought to investigate if short-acting, inhaled beta2-adrenergic receptor agonists were associated with higher risk of primary cardiac arrest in patients…”
Get more information

Platelet glycoprotein IIb polymorphism, traditional risk factors and non‐fatal myocardial infarction in young women by Reiner, Alexander P., Schwartz, Stephen M., Kumar, Prasanna N., Rosendaal, Frits R., Pearce, Rachel M., Aramaki, Kaelen M., Psaty, Bruce M., Siscovick, David S.

“…Several platelet glycoprotein polymorphisms have been associated with an increased risk of myocardial infarction (MI) in studies that included predominantly…”
Get full text

Digoxin therapy and the risk of primary cardiac arrest in patients with congestive heart failure: Effect of mild–moderate renal impairment by Rea, Thomas D., Siscovick, David S., Psaty, Bruce M., Pearce, Rachel M., Raghunathan, Trivellore E., Whitsel, Eric A., Cobb, Leonard A., Weinmann, Sheila, Anderson, Gail D., Arbogast, Patrick, Lin, Danyu

“…Background and Objective: The cardiac safety of digoxin therapy for congestive heart failure (CHF) is a source of concern, especially among those with renal…”
Get full text

Factor V leiden, prothrombin g20210a, and risk of sudden coronary death in apparently healthy persons by Reiner, Alexander P, Rosendaal, Frits R, Reitsma, Pieter H, Lemaitre, Rozenn N, Pearce, Rachel M, Friedlander, Yechiel, Raghunathan, Trivellore E, Psaty, Bruce M, Siscovick, David S

“…We performed a population-based case-control study of 145 cases of sudden coronary death without previously recognized heart disease and 592 healthy controls…”
Get full text

Pediatric adapted risk index to predict 2-year transplant-related mortality post-HSCT in children by Elfeky, Reem, Builes, Natalia, Pearce, Rachel, Kania, Soumya, Nademi, Zohreh, Lucchini, Giovanna, Chiesa, Robert, Amrolia, Persis, Sorror, Mohamed, Veys, Paul, Rao, Kanchan

“…•To our knowledge, this is the first pediatric tailored HSCT index combining RFs with CoMs in 1 scoring model.•PARI will be a significant tool for pediatric…”
Get full text

Long-Term Outcome of Unrelated Donor Transplantation for AML Using Myeloablative Conditioning Incorporating Pretransplant Alemtuzumab by Das-Gupta, Emma P, Russell, Nigel H, Shaw, Bronwen E, Pearce, Rachel M, Byrne, Jennifer L

“…Abstract The outcome of 55 patients who underwent matched unrelated donor (MUD) transplantation for acute myelogenous leukemia (AML) following a conditioning…”
Get full text

Long-Term Outcomes of Myeloablation and Autologous Transplantation of Relapsed Acute Myeloid Leukemia in Second Remission: A British Society of Blood and Marrow Transplantation Registry Study by Chantry, Andrew D., Snowden, John A., Craddock, Charles, Peggs, Karl, Roddie, Claire, Craig, Jenny I.O., Orchard, Kim, Towlson, Keiren E., Pearce, Rachel M., Marks, David I.

“…Relapsed acute myeloid leukemia (AML) in adults has a poor prognosis if treated with chemotherapy alone. Case series have previously supported the role of…”
Get full text

Allogeneic Stem Cell Transplantation Induces Long Term Survival in Pateitns with Advanced Chronic Myeloid Leukaemia:A Study of the British Society for Blood and Marrow Transplantation by Cook, Gordon, Kirkland, Keiren, Lee, Julia, Pearce, Rachel M, Apperley, Jane F, Clark, Richard E., Mackinnon, Stephen, Marks, David I.

“…Abstract 4125 The tyrosine kinase inhibitor (TKI), imatinib mesylate, is first-line therapy for patients with CML, and consequently, the use of alloSCT has…”
Get full text

The Outcome of Sibling and Unrelated Donor Allogeneic Stem Cell Transplantation in Adult Patients with Acute Myeloid Leukemia in First Remission Who Were Initially Refractory to First Induction Chemotherapy by Cook, Gordon, Clark, Richard E., Crawley, Charles, Mackinnon, Stephen, Russell, Nigel, Thomson, Kirsty, Pearce, Rachel M., Towlson, Keiren, Marks, David I.

“…The optimal management of patients with initially refractory acute myeloid leukemia is unknown. We analyzed the outcomes of 68 adult patients (median age, 37…”
Get full text